In early September, Lactalis Ingredients Pharma and Safic-Alcan confirmed an exclusive distributorship agreement for the distribution of pharmaceutical lactose in multiple countries including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Romania, Slovakia, Slovenia, Sweden, Egypt, Morocco, Algeria, and Tunisia.
Guarantying a sustainable and reliable supply
This partnership across Europe and North Africa is a strategic decision for Lactalis Ingredients Pharma: “we wish to supply Europe durably and locally with our integrated French raw liquid whey resource”. As the first cheese producer in the world, Lactalis Ingredients Pharma profits from a massive and consistent supply from the cheese factories of Lactalis Group.
Across many countries of western Europe and north Africa, we, at Lactalis Ingredients Pharma have selected Safic-Alcan as our exclusive distributor as we fully trust their market expertise and the reliability of their supply chain. With their on-site commercial teams and own warehouses, we are fully confident to be able to supply our customers everywhere and at any time.
Moreover, we are proud to work with a sustainable partner, as Safic-Alcan has a culture of continuous improvement, innovation, and responsibility. This position resonates with our own DNA, since our lactose is produced in our ISO 14001 certified site of Retiers, that also works actively on energy transition and water consumption reduction.
Safic-Alcan, a privileged partner
Safic-Alcan is a world-renown distributor that manages a wide portfolio of APIs, excipients, biotechs and analytical standards for the pharmaceutical industry. Thanks to the strong support of their global teams and their knowledge of the market, Safic-Alcan is a precious partner for Lactalis Ingredients Pharma’s launch. Thanks to Safic-Alcan’s wide portfolio of APIs and excipients, our clients can expect to source their OSD formulation with a single reliable distributor.
With the target of enabling quick and smart access to pharmaceutical ingredients, Safic-Alcan provides support for their clients at every stage of the product development cycle, thus perfectly completing the safe lactose supply of Lactalis Ingredients Pharma.
An emphasis on the Lactalpha range
Lactalpha is our range of milled and sieved lactose monohydrate, available in various mesh sizes to fit your OSD applications. Manufactured in Retiers, France, Lactalpha embodies the expertise of Lactalis Ingredients Pharma and its strong commitment to pharmaceutical quality. Compliant to the current monographs of the Pharmacopoeias (Ph. Eur., USP-NF and JP), our lactose is a stable and consistent excipient.
Discover our range for your OSD applications:
- Lactalpha 50: 50 mesh sieved lactose monohydrate. Recommended for dry blending thanks to its good flowability, Lactalpha 50 is a diluent for capsule and sachet filling.
- Lactalpha 100: 100 mesh milled lactose monohydrate. Recommended for dry blending thanks to its good flowability, Lactalpha 100 is a diluent for capsule and sachet filling.
- Lactalpha 150: 150 mesh milled lactose monohydrate. Recommended for wet and dry granulation, Lactalpha 150 is a good diluent and tablet binder. It can be used for the formulation of tablets, capsules, and sachets.
Learn more about our partnership
Safic-Alcan is hosting a webinar on the 11th of January 2024 to present our partnership and the Lactalpha range distribution. Register or watch the replay if you wish to optimize your lactose supply chain, learn about strategies for sustainable sourcing of explore the customer-centric collaboration between Safic-Alcan and Lactalis Ingredients Pharma.
Watch our webinar “A reliable and sustainable source of pharma lactose made in France” here
